copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Does propranolol have a role in cancer treatment? A systematic review . . . This systematic review aims to assess the evidence for the repurposing of propranolol as a treatment for various cancers, particularly breast cancer to answer the research question: Does propranolol improve cancer outcomes, including survival and recurrence?
Propranolol and breast cancer—a work in progress Abstract The non-selective beta-blocker propranolol is a leading candidate for repurposing as a novel anti-cancer agent Emerging evidence, including human data, suggests that there are multiple mechanisms of action particularly relevant to breast cancer
Propranolol - Repurpose Drugs - The Beat Cancer Foundation As research rapidly advances, we're witnessing Propranolol’s impressive potential as a therapeutic agent in combating a range of cancers, including those of the breast, lung, ovary, and colon
Drugs repurposed: An advanced step towards the treatment of breast . . . So many drugs are repurposed for the BC, including alkylating agents, antimetabolite, anthracyclines, an aromatase inhibitor, mTOR, and many more The drug resistance in breast cancer is rising, so reviewing how the challenges in breast cancer can be combated with drug repurposing
Evidence of β-blockers drug repurposing for the treatment of triple . . . Key words: triple negative breast cancer, β-blockers, systematic review, drug repurposing, propranolol econd mposed of several biological subtypes having diferent prognosis and outcome Based on the immunohistochemical classification, approximately 16% of all the BCs do not express estrogen receptors, progesterone recepto
Repurposing Drugs in Oncology (ReDO)—Propranolol as an anti-cancer . . . In addition to clinical use in these varied indications there is accumulating evidence that propranolol has potent anti-cancer effects, as evidenced by in vitro, in vivo and a range of clinical data The PRO dose varies by indication